Management of Metformin-Associated Lactic Acidosis

Critical Actions

The patient meets multiple high-risk criteria for MALA, including not eating for 5 days, elevated BHB suggesting starvation ketosis with metabolic stress, markedly elevated GGT indicating liver impairment, and pancreatic atrophy suggesting chronic pancreatitis, and therefore should stop metformin immediately 1, 2, 3
The patient has multiple overlapping risk factors creating a perfect storm, including starvation state, liver dysfunction, high metformin dose, and pancreatic atrophy, which increases the risk of MALA 1, 2, 3
Do not restart metformin until the acute illness resolves, liver function normalizes, patient resumes normal oral intake, and renal function is reassessed 1, 2, 3

Reassess the appropriateness of metformin given pancreatic atrophy, liver dysfunction, and this severe complication, and consider alternative glucose-lowering agents such as SGLT2 inhibitors or insulin therapy 1, 2, 3, 4, 5, 6
If metformin is restarted, the dose must be reduced to a maximum of 1000 mg daily given the multiple risk factors, and only after resolution of acute illness and normalization of organ function 4, 5, 6